Clinical Trial of Jelly Containing the Rare Sugar D-Alulose in Patients with Type 2 Diabetes Mellitus

Not Applicable

Recruiting

• Conditions: Type 2 diabetes; D-allulose; MeSH Unique ID: D003924

• Registration Number: JPRN-jRCTs061230021
• Lead Sponsor: Fukunaga Kensaku

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-06-07
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

1. patients with type 2 diabetes who are 20 years of age or older at the time of obtaining consent
2. patients with type 2 diabetes who are hospitalized in our hospital.
3. patients who can give written consent to participate in this study.

Exclusion Criteria

1. patients taking alpha-glucosidase inhibitors
2. patients who have experienced serious adverse reactions to D-alulose in the past
3. pregnant, lactating, or nursing women, or women of childbearing potential
4. patients with severe renal dysfunction (serum eGFR < 15 ml/min/1.73m2)
5. patients with other serious complications
6. patients who are participating in other studies
7. if, in the opinion of the Principal Investigator, participation in the research would not be in the best interest of the research subjects (e.g., would be detrimental to the welfare of the research subjects) or would interfere with, limit, or confound the evaluation specific to the clinical research protocol
8. an employee of the Principal Investigator or the institution, or a family member of such an employee or Principal Investigator, who is directly involved in this or other clinical research at the direction of the Principal Investigator or the institution.

Study & Design

• Study Type: Interventional
• Study Design: Not specified